122 related articles for article (PubMed ID: 38712662)
1. Intracellular infection-responsive macrophage-targeted nanoparticles for synergistic antibiotic immunotherapy of bacterial infection.
Dai X; Li Y; Liu X; Zhang Y; Gao F
J Mater Chem B; 2024 May; 12(21):5248-5260. PubMed ID: 38712662
[TBL] [Abstract][Full Text] [Related]
2. Cascade-Targeted Nanoplatforms for Synergetic Antibiotic/ROS/NO/Immunotherapy against Intracellular Bacterial Infection.
Dai X; Liu X; Wang X; Zhang Y; Li Y; Gao F
Biomacromolecules; 2024 May; 25(5):3190-3199. PubMed ID: 38693753
[TBL] [Abstract][Full Text] [Related]
3. Cellular uptake and
Subramaniam S; Joyce P; Conn CE; Prestidge CA
Biomater Sci; 2024 Jun; 12(13):3411-3422. PubMed ID: 38809118
[TBL] [Abstract][Full Text] [Related]
4. Potent antibacterial nanoparticles for pathogenic bacteria.
Lai HZ; Chen WY; Wu CY; Chen YC
ACS Appl Mater Interfaces; 2015 Jan; 7(3):2046-54. PubMed ID: 25584802
[TBL] [Abstract][Full Text] [Related]
5. pH-Responsive Lipid-Dendrimer Hybrid Nanoparticles: An Approach To Target and Eliminate Intracellular Pathogens.
Maji R; Omolo CA; Agrawal N; Maduray K; Hassan D; Mokhtar C; Mackhraj I; Govender T
Mol Pharm; 2019 Nov; 16(11):4594-4609. PubMed ID: 31593478
[TBL] [Abstract][Full Text] [Related]
6. Pillar[5]arene-based, dual pH and enzyme responsive supramolecular vesicles for targeted antibiotic delivery against intracellular MRSA.
Peng H; Xie B; Yang X; Dai J; Wei G; He Y
Chem Commun (Camb); 2020 Jul; 56(58):8115-8118. PubMed ID: 32691784
[TBL] [Abstract][Full Text] [Related]
7. Synergetic effect of vancomycin loaded silver nanoparticles for enhanced antibacterial activity.
Kaur A; Preet S; Kumar V; Kumar R; Kumar R
Colloids Surf B Biointerfaces; 2019 Apr; 176():62-69. PubMed ID: 30594704
[TBL] [Abstract][Full Text] [Related]
8. Combating Intracellular Pathogens with Nanohybrid-Facilitated Antibiotic Delivery.
Bose RJC; Tharmalingam N; Choi Y; Madheswaran T; Paulmurugan R; McCarthy JR; Lee SH; Park H
Int J Nanomedicine; 2020; 15():8437-8449. PubMed ID: 33162754
[TBL] [Abstract][Full Text] [Related]
9. Nitrogen-phosphorous co-doped carbonized chitosan nanoparticles for chemotherapy and ROS-mediated immunotherapy of intracellular Staphylococcus aureus infection.
Dai X; Liu X; Li Y; Xu Q; Yang L; Gao F
Carbohydr Polym; 2023 Sep; 315():121013. PubMed ID: 37230629
[TBL] [Abstract][Full Text] [Related]
10. Poly(lactic-
Maghrebi S; Joyce P; Jambhrunkar M; Thomas N; Prestidge CA
ACS Appl Mater Interfaces; 2020 Feb; 12(7):8030-8039. PubMed ID: 32013379
[TBL] [Abstract][Full Text] [Related]
11. Bacteria-responsive multifunctional nanogel for targeted antibiotic delivery.
Xiong MH; Li YJ; Bao Y; Yang XZ; Hu B; Wang J
Adv Mater; 2012 Dec; 24(46):6175-80. PubMed ID: 22961974
[TBL] [Abstract][Full Text] [Related]
12. Targeting Intracellular Bacteria with Dual Drug-loaded Lactoferrin Nanoparticles.
Andima M; Boese A; Paul P; Koch M; Loretz B; Lehr CM
ACS Infect Dis; 2024 May; 10(5):1696-1710. PubMed ID: 38577780
[TBL] [Abstract][Full Text] [Related]
13. ROS-sensitive micelles for controlled delivery of antibiotics to combat intracellular
Qiao J; Cui S; Xiong MP
J Mater Chem B; 2021 Nov; 9(43):8951-8961. PubMed ID: 34606554
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin-loaded nanoparticles against vancomycin intermediate and methicillin resistant Staphylococcus aureus strains.
Simon A; Moreira MLA; Costa IFJB; de Sousa VP; Rodrigues CR; da Rocha E Lima LMT; Sisnande T; do Carmo FA; Leal ICR; Dos Santos KRN; da Silva LCRP; Cabral LM
Nanotechnology; 2020 Sep; 31(37):375101. PubMed ID: 32470951
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnology as a therapeutic tool to combat microbial resistance.
Pelgrift RY; Friedman AJ
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
[TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of antibiotics to the infected pulmonary tissues using ROS-responsive nanoparticles.
Wang Y; Yuan Q; Feng W; Pu W; Ding J; Zhang H; Li X; Yang B; Dai Q; Cheng L; Wang J; Sun F; Zhang D
J Nanobiotechnology; 2019 Oct; 17(1):103. PubMed ID: 31581948
[TBL] [Abstract][Full Text] [Related]
17. Liquid crystalline lipid nanoparticles improve the antibacterial activity of tobramycin and vancomycin against intracellular Pseudomonas aeruginosa and Staphylococcus aureus.
Subramaniam S; Joyce P; Prestidge CA
Int J Pharm; 2023 May; 639():122927. PubMed ID: 37059243
[TBL] [Abstract][Full Text] [Related]
18. Facile Assembly of Multifunctional Antibacterial Nanoplatform Leveraging Synergistic Sensitization between Silver Nanostructure and Vancomycin.
Ma K; Dong P; Liang M; Yu S; Chen Y; Wang F
ACS Appl Mater Interfaces; 2020 Feb; 12(6):6955-6965. PubMed ID: 31977179
[TBL] [Abstract][Full Text] [Related]
19. Alendronate-decorated biodegradable polymeric micelles for potential bone-targeted delivery of vancomycin.
Cong Y; Quan C; Liu M; Liu J; Huang G; Tong G; Yin Y; Zhang C; Jiang Q
J Biomater Sci Polym Ed; 2015; 26(11):629-43. PubMed ID: 25994241
[TBL] [Abstract][Full Text] [Related]
20. Pathogen-Activated Macrophage Membrane Encapsulated CeO
Li W; Qi M; Zhou J; Sun Y; Sun J; Dong B; Wang L; Song S
Small; 2024 May; 20(19):e2309664. PubMed ID: 38057126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
